1) chronic liver disease
慢性肝疾病
1.
Influence of chronic liver disease on the activity of CYP450s;
慢性肝疾病对肝CYP450酶活性的影响
2) chronic diseases
慢性疾病
1.
Investigations of accompanying relative s life quality of patients with chronic diseases;
慢性疾病患者陪护亲属的生活质量调查
2.
The analysis of the insured and uninsured inpatient with five kinds of chronic diseases expenses
5种慢性疾病医保与非医保患者住院费用分析
3.
This review provides an insight into garlic's antioxidant properties,and presents evidence that it may either prevent or delay chronic diseases associated with aging.
探索了大蒜的抗氧化特性 ,并提供证据说明其可能预防和延缓与老年有关的慢性疾病。
3) chronic disease
慢性疾病
1.
Study on experiences of nursing specialty students understanding chronic diseases through art;
护理专业学生通过艺术理解慢性疾病的学习体会研究
2.
Investigation of chronic diseases and medical costs among rural adults in Fuxin area;
阜新市农村居民慢性疾病患病及经济负担调查
3.
Investigation of prevalent rate of cholelithiasis and correlated chronic disease of middle-aged and elderly people serving in government in Chongqing
重庆市市区中老年公职人员胆石症发病率及其相关慢性疾病的调查分析
4) chronic liver disease
慢性肝病
1.
Changes of serum argininosuccinate lyase levels in patients with chronic liver diseases;
慢性肝病患者血清精氨[基]琥珀酸裂合酶的变化
2.
A survey of influencing factors of chronic liver disease patients with sleep disorder;
慢性肝病病人睡眠障碍的影响因素调查
3.
A study on sleeping state of patients with chronic liver disease;
慢性肝病病人的睡眠状况研究
5) Chronic liver diseases
慢性肝病
1.
Objective To study the correlation between serum level of PCⅢ and the degree of liver fibrosis in patients with chronic liver diseases.
目的:探讨慢性肝病患者血清Ⅲ型前胶原(PCⅢ)水平与肝纤维化病变程度的相关性及进程的分级判定作用。
2.
The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases.
结果表明 :慢性肝病患者血清中 HA和 SCG的含量显著高于对照组 ( P<0 。
3.
Objective:To reevaluate the blood endotoxin concentration in patients with chronic liver diseases by means of dynamic turbidimetric analysis.
目的:采用动态浊度法对慢性肝病患者血、腹水中内毒素水平进行再评估。
6) Chronic hepatopathy
慢性肝病
1.
Application of protein chip technology for investigation of changes of various serum cytokines in patients with chronic hepatopathy;
应用蛋白芯片技术观察慢性肝病患者血清细胞因子的变化规律
2.
Methods 18 normal rats and 36 chronic hepatopathy rats divided into:①normal ofloxacin protective group; ②normal PGE2 immuno-intervention group;③hepatopathy ofloxacin protective group;④hepatopathy PGE2 immuno-intervention combined ofloxacin protective group;⑤hepatopathy negative group; ⑥ hepa.
方法取18只正常大鼠和36只慢性肝病大鼠,随机分成:①正常氧氟沙星治疗组;②正常PGE2免疫干预与氧氟沙星联合保护组;③肝病氧氟沙星等药物治疗组;④肝病PGE2免疫干预与氧氟沙星等药物联合保护组;⑤肝病大鼠阴性对照组;⑥肝病大鼠Vv攻击对照组(n=9)。
3.
Methods: Eighteen chronic hepatopathy rats which were prepared by carbon tetrachloride were divided into Vv attack group and control group to make multiple organ dysfunction hepatopathy rat models of Vv lethal infection (5.
方法：采用四氯化碳制备慢性肝病大鼠18只,分Vv攻击和肝病大鼠对照组(n=9),Vv致死性感染多器官损伤肝病大鼠模型(5。
补充资料：慢性消耗性疾病
慢性消耗性疾病
wastingdisease
由于疾病反复发作或发热，导致食欲不振，摄食减少，或由于食物不能充分吸收利用，以致不能维持正常代谢，迫使机体消耗自身的组织，出现体重不增或减轻，生长发育停滞，脂肪逐渐消失，肌肉萎缩，同时也可造成全身各系统的功能紊乱，免疫力低下。本病可由于能量营养不良或蛋白质缺少所致。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条